Skip to main content
Premium Trial:

Request an Annual Quote

Rheonix: Roy Proujansky, Irving Nachamkin

Rheonix has named Roy Proujansky and Irving Nachamkin to its board of directors.

Proujansky has served for more than 30 years in physician, hospital, and health system leadership positions. At Nemours Children's Hospital, his roles included chief executive for the physician practice, chief operating officer for the Nemours Children's Health System, and chief executive for the DuPont Hospital for Children and Delaware Valley Operations. He is currently a professor of pediatrics at the Sidney Kimmel College of Medicine at Thomas Jefferson University.

Nachamkin is professor emeritus of pathology and laboratory medicine and the immediate past director of the division of laboratory medicine and associate director of the clinical microbiology laboratory at the Perelman School of Medicine and Hospital of the University of Pennsylvania. He is an expert in clinical microbiology with a focus on laboratory diagnostics, molecular diagnostics in infectious diseases, and laboratory management, and is a fellow of the American Academy of Microbiology, Infectious Diseases Society of America, and College of Physicians of Philadelphia.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.